Minn. R. agency 144, ch. 4615, METABOLIC DEFECT TESTING, TREATMENT, AND REGISTRY, pt. 4615.0750

Current through Register Vol. 49, No. 11, September 9, 2024

Part 4615.0750 - PURPOSE AND SCOPE

The purpose and scope of parts 4615.0750 to 4615.0760 is to describe the responsibilities of the Minnesota Department of Health to assure that persons diagnosed as having hemoglobinopathy, phenylketonuria, galactosemia, hypothyroidism, and/or congenital adrenal hyperplasia will:

(1) have access to approved laboratory treatment control tests when available;

(2) have necessary financial assistance for treatment of diagnosed cases when indicated; and

(3) be included in a registry of cases for the purpose of coordinating follow-up services.

Minn. R. agency 144, ch. 4615, METABOLIC DEFECT TESTING, TREATMENT, AND REGISTRY, pt. 4615.0750

10 SR 2290; 17 SR 1758

Statutory Authority: MS s 144.125; 144.128